ArriVent BioPharma, Inc. Common Stock

AVBP

AVBPArriVent BioPharma, Inc. Common Stock US flag

NASDAQ Global Market

29.78

USD

-0.14

- -

1.39BMarket Cap

Profitability (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-32.68	-40.08	-36.75	-54.7
Return on Capital (%)	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -
Net Debt/EBITDA	- -	4.43	2.02	0.79	0.26
Total Debt/EBIT	- -	- -	- -	- -	- -
Net Debt/EBIT	- -	4.43	2.02	0.79	0.26
EBITDA to Interest Expense	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -
Common Equity/Total Assets	-119.91	-48.41	-96.78	-86.68	-121.45
Long-Term Debt/Equity (%)	- -	- -	- -	0.01	- -
Long-Term Debt/Capital (%)	- -	-0.01	-0.11	-0.01	- -
Long-Term Debt/Total Assets (%)	- -	0.01	0.11	0.01	- -
Total Debt/Equity (%)	- -	-0.16	-0.21	0.07	- -
Total Debt/Capital (%)	- -	-0.16	-0.2	-0.07	- -
Total Debt/Total Assets (%)	- -	0.08	0.19	0.06	- -
Net Debt to Equity	-90.44	191.96	98.17	-28.83	-14.82
Net Debt/Capital (%)	-3,807.97	64.9	48.84	23.78	10.12
EBITDA	- -	-37	-75	-94	-178
EBITDA-CapEx	- -	-37	-75	-94	-178
Operating Income (Loss)	- -	-37	-75	-94	-178

Liquidity (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	20.51	19.54	12.94	12.67	12.06
Current Ratio	23.63	21.84	13.76	13.14	12.83
Quick Ratio	20.64	19.6	13	12.7	12.06
CFO/Avg Current Liab	- -	-8.57	-5.59	-4.86	-7.43
Common Equity/Total Assets	-119.91	-48.41	-96.78	-86.68	-121.45
Long-Term Debt/Equity (%)	- -	- -	- -	0.01	- -
Long-Term Debt/Capital (%)	- -	-0.01	-0.11	-0.01	- -
Long-Term Debt/Total Assets (%)	- -	0.01	0.11	0.01	- -
Total Debt/Equity (%)	- -	-0.16	-0.21	0.07	- -
Total Debt/Capital (%)	- -	-0.16	-0.2	-0.07	- -
Total Debt/Total Assets (%)	- -	0.08	0.19	0.06	- -
CFO/Total Liabilities	- -	-16.28	-17.66	-406.13	-618.96
CFO/CapEx	- -	- -	- -	- -	- -
Altman's Z-Score	-0.53	-0.2	-1.77	27.67	-2.35

Working Capital (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	838	- -
- Cash & Cash Equivalents	37	163	150	74	46
+ Preferred Equity and Hybrid Capital	90	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -
Enterprise Value	53	-163	-150	620	-313
Total Capital	38	-88	-158	-238	-405
Total Debt/Capital (%)	- -	-0.16	-0.2	-0.07	- -
Total Debt / EV	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	838	- -
Diluted Enterprise Value	53	-163	-150	764	-46
EV per Share	- -	- -	- -	19.69	- -
TTM Sales	- -	- -	- -	- -	- -
TTM EBITDA	- -	-37	-75	-94	-178
TTM Operating Income	- -	-37	-75	-94	-178
TTM Cash Flow to Firm	- -	-44	-56	-70	-161
TTM Free Cash Flow to Firm	- -	-44	-56	-70	-161

Multiples (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	-11.94	- -
EV/EBIT	- -	- -	- -	- -	- -
Enterprise Value	53	-163	-150	620	-313
Low Price	- -	- -	- -	14.35	15.47
EV/Sales	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-8.82	- -
Price/Earnings High	- -	- -	- -	-14.22	- -
Price/Earnings Low	- -	- -	- -	-5.61	- -
Price/Book Value	- -	- -	- -	-3.52	- -
Price/Book Value Average	- -	- -	- -	-2.98	- -
Price/Book Value High	- -	- -	- -	-4.8	- -
Price/Book Value Low	- -	- -	- -	-1.89	- -
Price/Tangible Book Value	- -	- -	- -	3.25	- -
Price/Tangible Book Value Average	- -	- -	- -	2.76	- -
Price/Tangible Book Value High	- -	- -	- -	4.44	- -
Price/Tangible Book Value Low	- -	- -	- -	1.75	- -
Price/Sales	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-11.94	- -
Price/Cash Flow Average	- -	- -	- -	-10.11	- -
Price/Cash Flow High	- -	- -	- -	-16.3	- -
Price/Cash Flow Low	- -	- -	- -	-6.43	- -
Price/Free Cash Flow Average	- -	- -	- -	-10.11	- -
Price/Free Cash Flow High	- -	- -	- -	-16.3	- -
Price/Free Cash Flow Low	- -	- -	- -	-6.43	- -
EV/Sales Average	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -
EV/EBITDA Average	- -	4.42	2.01	-6.74	0.26
EV/EBITDA High	- -	4.42	2.01	-11.35	0.26
EV/EBITDA Low	- -	4.42	2.01	-4	0.26
EV/EBIT Average	- -	4.42	2.01	-6.74	0.26
EV/EBIT High	- -	4.42	2.01	-11.35	0.26
EV/EBIT Low	- -	4.42	2.01	-4	0.26
Last Price	- -	- -	- -	26.64	20.12
High Price	- -	- -	- -	36.37	29.71
Enterprise Value Average	53	-163	-150	636	-46
Enterprise Value High	53	-163	-150	1,070	-46
Enterprise Value Low	53	-163	-150	377	-46

Profitability (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-32.68	-40.08	-36.75	-54.7
Return on Capital (%)	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -
ST Debt	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -
Net Debt/EBITDA	- -	4.43	2.02	0.79	0.26
Total Debt/EBIT	- -	- -	- -	- -	- -
Net Debt/EBIT	- -	4.43	2.02	0.79	0.26
EBITDA to Interest Expense	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -
Common Equity/Total Assets	-119.91	-48.41	-96.78	-86.68	-121.45
Long-Term Debt/Equity (%)	- -	- -	- -	0.01	- -
Long-Term Debt/Capital (%)	- -	-0.01	-0.11	-0.01	- -
Long-Term Debt/Total Assets (%)	- -	0.01	0.11	0.01	- -
Total Debt/Equity (%)	- -	-0.16	-0.21	0.07	- -
Total Debt/Capital (%)	- -	-0.16	-0.2	-0.07	- -
Total Debt/Total Assets (%)	- -	0.08	0.19	0.06	- -
Net Debt to Equity	-90.44	191.96	98.17	-28.83	-14.82
Net Debt/Capital (%)	-3,807.97	64.9	48.84	23.78	10.12
EBITDA	- -	-37	-75	-94	-178
EBITDA-CapEx	- -	-37	-75	-94	-178
Operating Income (Loss)	- -	-37	-75	-94	-178

Liquidity (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	20.51	19.54	12.94	12.67	12.06
Current Ratio	23.63	21.84	13.76	13.14	12.83
Quick Ratio	20.64	19.6	13	12.7	12.06
CFO/Avg Current Liab	- -	-8.57	-5.59	-4.86	-7.43
Common Equity/Total Assets	-119.91	-48.41	-96.78	-86.68	-121.45
Long-Term Debt/Equity (%)	- -	- -	- -	0.01	- -
Long-Term Debt/Capital (%)	- -	-0.01	-0.11	-0.01	- -
Long-Term Debt/Total Assets (%)	- -	0.01	0.11	0.01	- -
Total Debt/Equity (%)	- -	-0.16	-0.21	0.07	- -
Total Debt/Capital (%)	- -	-0.16	-0.2	-0.07	- -
Total Debt/Total Assets (%)	- -	0.08	0.19	0.06	- -
CFO/Total Liabilities	- -	-16.28	-17.66	-406.13	-618.96
CFO/CapEx	- -	- -	- -	- -	- -
Altman's Z-Score	-0.53	-0.2	-1.77	27.67	-2.35

Working Capital (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	838	- -
- Cash & Cash Equivalents	37	163	150	74	46
+ Preferred Equity and Hybrid Capital	90	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -
Enterprise Value	53	-163	-150	620	-313
Total Capital	38	-88	-158	-238	-405
Total Debt/Capital (%)	- -	-0.16	-0.2	-0.07	- -
Total Debt / EV	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	838	- -
Diluted Enterprise Value	53	-163	-150	764	-46
EV per Share	- -	- -	- -	19.69	- -
TTM Sales	- -	- -	- -	- -	- -
TTM EBITDA	- -	-37	-75	-94	-178
TTM Operating Income	- -	-37	-75	-94	-178
TTM Cash Flow to Firm	- -	-44	-56	-70	-161
TTM Free Cash Flow to Firm	- -	-44	-56	-70	-161

Multiples (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	-11.94	- -
EV/EBIT	- -	- -	- -	- -	- -
Enterprise Value	53	-163	-150	620	-313
Low Price	- -	- -	- -	14.35	15.47
EV/Sales	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-8.82	- -
Price/Earnings High	- -	- -	- -	-14.22	- -
Price/Earnings Low	- -	- -	- -	-5.61	- -
Price/Book Value	- -	- -	- -	-3.52	- -
Price/Book Value Average	- -	- -	- -	-2.98	- -
Price/Book Value High	- -	- -	- -	-4.8	- -
Price/Book Value Low	- -	- -	- -	-1.89	- -
Price/Tangible Book Value	- -	- -	- -	3.25	- -
Price/Tangible Book Value Average	- -	- -	- -	2.76	- -
Price/Tangible Book Value High	- -	- -	- -	4.44	- -
Price/Tangible Book Value Low	- -	- -	- -	1.75	- -
Price/Sales	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-11.94	- -
Price/Cash Flow Average	- -	- -	- -	-10.11	- -
Price/Cash Flow High	- -	- -	- -	-16.3	- -
Price/Cash Flow Low	- -	- -	- -	-6.43	- -
Price/Free Cash Flow Average	- -	- -	- -	-10.11	- -
Price/Free Cash Flow High	- -	- -	- -	-16.3	- -
Price/Free Cash Flow Low	- -	- -	- -	-6.43	- -
EV/Sales Average	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -
EV/EBITDA Average	- -	4.42	2.01	-6.74	0.26
EV/EBITDA High	- -	4.42	2.01	-11.35	0.26
EV/EBITDA Low	- -	4.42	2.01	-4	0.26
EV/EBIT Average	- -	4.42	2.01	-6.74	0.26
EV/EBIT High	- -	4.42	2.01	-11.35	0.26
EV/EBIT Low	- -	4.42	2.01	-4	0.26
Last Price	- -	- -	- -	26.64	20.12
High Price	- -	- -	- -	36.37	29.71
Enterprise Value Average	53	-163	-150	636	-46
Enterprise Value High	53	-163	-150	1,070	-46
Enterprise Value Low	53	-163	-150	377	-46

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	32	32	32	34	42
Diluted Weighted Avg Shares	- -	32	32	31	- -
Basic Weighted Avg Shares	- -	32	32	31	- -
Revenue per Share	- -	- -	- -	- -	- -
EBITDA per Share	- -	-1.15	-2.33	-3	- -
Operating Income per Share	- -	-1.15	-2.33	-3	- -
Basic EPS, GAAP	- -	-1.15	-2.17	-2.56	- -
Basic EPS from Cont Ops	- -	-1.15	-2.17	-2.56	- -
Diluted EPS, GAAP	- -	-1.15	-2.17	-2.56	- -
Diluted EPS from Cont Ops	- -	-1.15	-2.17	-2.56	- -
Dividend per Share	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-1.37	-1.75	-2.23	- -
Free Cash Flow per Basic Share	- -	-1.37	-1.75	-2.23	- -
Cash & Equivalents per Share	- -	5.11	4.71	6.95	- -
Book Value per Share	- -	-2.77	-4.94	-7.57	- -
Tangible Book Value per Share	- -	-2.66	-4.79	8.19	- -

ArriVent BioPharma, Inc. Common Stock

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)